EUVIMEDEUVIMED entdecken
Open Access

Vision-Related Quality of Life in Patients with Inherited Retinal Dystrophies

Saeideh Shojaei, Hamideh Sabbaghi, Yadollah Mehrabi, Narsis Daftarian, Koorosh Etemad, Hamid Ahmadieh

Journal of Current Ophthalmology · 2022-01 · 34 (1) · 80-86

DOI: 10.4103/joco.joco_172_21 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Current Ophthalmology, 2022-01. Verfasst von Saeideh Shojaei und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To evaluate the effect of inherited retinal dystrophies (IRDs) on vision-related quality of life (VRQoL) among IRDs' patients in Iran.

Methods

This cross-sectional study was conducted on 192 patients with different types of IRDs who were randomly selected from registered patients in the Iranian National Registry for Inherited Retinal Dystrophy (IRDReg®). All ophthalmic findings were collected based on the recorded data in IRDReg®. Moreover, the eligible participants were interviewed to fill out the National Eye Institute Visual Functioning Questionnaire-25 (NEI VFQ-25) to assess their VRQoL. Ordinal logistic regression was used to evaluate the possible association of the different clinical and nonclinical factors such as demographic information, socioeconomic status, and visual function with VRQoL.

Results

The overall mean of a composite score of VRQoL was 45. All subscales obtained from the NEI VFQ-25 questionnaire except general health, mental health, and ocular pain had a significant negative correlation with logMAR best corrected visual acuity (BCVA) and near visual acuity variables. There was a statistically significant relationship between VRQoL and factors like age (odds ratio [OR] = 0.91, 95% confidence interval [CI]: 0.87–0.94), employment status (OR = 1.37, 95% CI: 1.05–4.74), logMAR BCVA (OR = 0.31, 95% CI: 0.19–0.49) and normal color vision (OR = 1.92, 95% CI: 1.74–5.01).

Conclusion

The VRQoL of patients with IRDs in this study was low. BCVA could be an indicator to show VRQoL.

Schlagwörter

Stichwörter der Autor:innen

Inherited retinal dystrophyNational eye institute visual functioning questionnaire-25Vision-related quality of life

Autor:innen und Institutionen

  • Department of Epidemiology, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Ophthalmic Epidemiology Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Ocular Tissue Engineering Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Zitieren

APA

Shojaei, S., Sabbaghi, H., Mehrabi, Y., Daftarian, N., Etemad, K., & Ahmadieh, H. (2022). Vision-Related Quality of Life in Patients with Inherited Retinal Dystrophies. Journal of Current Ophthalmology, 34(1), 80-86. https://doi.org/10.4103/joco.joco_172_21

Vancouver

Shojaei S, Sabbaghi H, Mehrabi Y, Daftarian N, Etemad K, Ahmadieh H. Vision-Related Quality of Life in Patients with Inherited Retinal Dystrophies. Journal of Current Ophthalmology. 2022;34(1):80-86. doi:10.4103/joco.joco_172_21

BibTeX
@article{Shojaei2022,
  author = {Shojaei, Saeideh and Sabbaghi, Hamideh and Mehrabi, Yadollah and Daftarian, Narsis and Etemad, Koorosh and Ahmadieh, Hamid},
  title = {Vision-Related Quality of Life in Patients with Inherited Retinal Dystrophies},
  journal = {Journal of Current Ophthalmology},
  year = {2022},
  volume = {34},
  number = {1},
  pages = {80--86},
  doi = {10.4103/joco.joco_172_21}
}
Kostenlos starten →